Credit Suisse’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-73,061
| Closed | -$353K | – | 3556 |
|
|
2020
Q1 | $353K | Sell |
73,061
-8,290
| -10% | -$40.1K | ﹤0.01% | 2716 |
|
|
2019
Q4 | $864K | Buy |
81,351
+49,403
| +155% | +$525K | ﹤0.01% | 2613 |
|
|
2019
Q3 | $333K | Buy |
31,948
+13,387
| +72% | +$140K | ﹤0.01% | 2994 |
|
|
2019
Q2 | $284K | Sell |
18,561
-2,019
| -10% | -$30.9K | ﹤0.01% | 3069 |
|
|
2019
Q1 | $266K | Buy |
20,580
+6,539
| +47% | +$84.5K | ﹤0.01% | 3070 |
|
|
2018
Q4 | $133K | Buy |
+14,041
| New | +$133K | ﹤0.01% | 3201 |
|
|
2018
Q3 | – | Sell |
-45,598
| Closed | -$732K | – | 3508 |
|
|
2018
Q2 | $732K | Buy |
+45,598
| New | +$732K | ﹤0.01% | 2785 |
|
|
2017
Q4 | – | Sell |
-16,756
| Closed | -$186K | – | 3709 |
|
|
2017
Q3 | $186K | Buy |
+16,756
| New | +$186K | ﹤0.01% | 3467 |
|
|
2017
Q1 | – | Sell |
-11,483
| Closed | -$123K | – | 3700 |
|
|
2016
Q4 | $123K | Buy |
+11,483
| New | +$123K | ﹤0.01% | 3551 |
|
|
2016
Q3 | – | Sell |
-10,567
| Closed | -$72K | – | 3900 |
|
|
2016
Q2 | $72K | Buy |
+10,567
| New | +$72K | ﹤0.01% | 3802 |
|
|
2015
Q3 | – | Sell |
-10,545
| Closed | -$124K | – | 4227 |
|
|
2015
Q2 | $124K | Buy |
+10,545
| New | +$124K | ﹤0.01% | 4055 |
|
|
2015
Q1 | – | Sell |
-23,809
| Closed | -$406K | – | 4237 |
|
|
2014
Q4 | $406K | Buy |
+23,809
| New | +$406K | ﹤0.01% | 3493 |
|
|
2014
Q3 | – | Sell |
-10,557
| Closed | -$155K | – | 4238 |
|
|
2014
Q2 | $155K | Sell |
10,557
-23,255
| -69% | -$341K | ﹤0.01% | 4019 |
|
|
2014
Q1 | $689K | Sell |
33,812
-9,660
| -22% | -$197K | ﹤0.01% | 3108 |
|
|
2013
Q4 | $852K | Buy |
+43,472
| New | +$852K | ﹤0.01% | 3001 |
|